IGF-1 LR3 For Sale USA — Research Grade Sourcing Guide 2026

IGF-1 LR3 is not simply IGF-1 with a different name — it is a structurally distinct analog with specific modifications engineered for research applications requiring reduced IGFBP binding and extended half-life. As covered in our complete LR3 guide, these structural differences are what make it the preferred IGF-1 research tool over native IGF-1 in most muscle and anabolic biology study designs.

The LR3 Structural Modifications — What to Verify

The "LR3" designation specifies two structural features: the N-terminal 13-amino-acid extension (the "L" for Long) and the arginine substitution at position 3 (the "R3"). Both features reduce binding to IGF binding proteins (IGFBPs) that would otherwise sequester native IGF-1 and limit its bioavailability. A supplier claiming to sell IGF-1 LR3 without mass spectrometry confirmation of the correct extended molecular weight is not verifying that both structural features are present.

What to Specifically Check on the COA

The molecular weight for correctly synthesized IGF-1 LR3 is approximately 9.1 kDa — substantially different from native IGF-1's 7.6 kDa due to the N-terminal extension. Any supplier COA showing a molecular weight inconsistent with this range has either failed to synthesize the LR3 form or is providing documentation for a different compound. HPLC purity above 98% is the baseline; the molecular weight confirmation is the specific LR3 verification that standard peptide sourcing criteria don't adequately cover.

Related Research IGF-1 LR3 Expanded Research Guide HGH and IGF-1 Axis Research PEG-MGF Research Guide Peptides for Lean Muscle Research Summer

Research Use Only. DisclaimerFor laboratory and research use only. Not for human consumption. This content is educational and does not constitute medical advice.